Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Emforal 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Pink, round, film-coated tablets. |
Each film-coated tablet contains 10 mg propranolol hydrochloride.
Excipient(s) with known effect:
This product contains 60.9 mg lactose and 0.093 mg carmoisine E122.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Propranolol |
Propranolol is a competitive antagonist at both beta, and beta2-adrenoceptor, but has membrane stabilising activity at concentrations exceeding 1-3mg/litre, though such concentrations are rarely achieved during oral therapy. Competitive beta-blockade has been demonstrated in man by a parallel shift to the right in the dose-heart rate response curve to beta-agonists such as isoprenaline. |
| List of Excipients |
|---|
|
Core: Cellulose, microcrystalline Coating: Hypromellose |
PVC/Aluminium blisters. Pack-size of 50 film-coated tablets.
PP containers with PE closure. Pack-sizes of 500 and 1000 tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
19733
Date of first authorisation: 08 November 2005
Date of latest renewal: 15 March 2011
| Drug | Countries | |
|---|---|---|
| EMFORAL | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
